Major Investors Retreat from UnitedHealth as Medical Costs Surge

A significant shift is occurring among UnitedHealth’s shareholder base, with institutional money managers leading a substantial sell-off. Recent regulatory filings reveal that several major investment firms have dramatically reduced their stakes in the healthcare giant, creating uncertainty about the company’s near-term prospects. This institutional exodus comes as UnitedHealth shares have declined approximately 40% since the start of the year, prompting questions about what’s driving professional investors away.

The primary concern centers on UnitedHealth’s Medical Care Ratio (MCR), which measures the percentage of premium revenue spent on medical services. This key metric has deteriorated alarmingly, climbing from a stable 82% in 2022 to a troubling 88% by the end of 2025. This Read more...